Together, these results indicate that these proteins, identified in the patient lung tumour matrisome, are increased in NSCLC and their corresponding gene expression provides prognostic information for lung adenocarcinoma (PXDN) or squamous cell carcinoma (ADAMTS16) patients undergoing curative intent surgery. The gene discussed is ADAMTS16; the disease is lung adenocarcinoma.